Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CYX8 | ISIN: KYG8708L1041 | Ticker-Symbol:
NASDAQ
03.05.24
16:28 Uhr
11,350 US-Dollar
+0,190
+1,70 %
1-Jahres-Chart
TENX KEANE ACQUISITION Chart 1 Jahr
5-Tage-Chart
TENX KEANE ACQUISITION 5-Tage-Chart

Aktuelle News zur TENX KEANE ACQUISITION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoTenX Keane Acquisition - 8-K, Current Report1
16.04.TenX Keane Acquisition - 10-K, Annual Report1
02.04.TenX Keane Acquisition - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4051
30.01.TenX Keane Acquisition - S-4/A, Registration of securities, business combinations1
18.01.TenX Keane Acquisition - 8-K, Current Report2
10.01.TenX Keane Acquisition - 8-K, Current Report1
10.01.TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal353New York, NY, Jan. 10, 2024 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (Nasdaq: TENKU, TENK, TENKR) (the "Company"), announced today that if the proposal to amend the Company's Amended and Restated...
► Artikel lesen
09.01.TenX Keane Asks for up to 10 More Months to Finalize Citius Oncology Deal8
20.11.23TenX Keane Acquisition - 10-Q, Quarterly Report1
13.11.23TenX Keane Acquisition - S-4, Registration of securities, business combinations1
24.10.23Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.210Citius Pharmaceuticals, Inc. to receive $675 million in equity of Citius Oncology, Inc. and retain approximately 90% majority control in publicly listed Citius Oncology, Inc. post transaction Transaction...
► Artikel lesen
18.10.23TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination114New York, NY, Oct. 18, 2023 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the "Company") (NASDAQ: TENKU) today announced that, in order to extend the date by which the Company must complete its initial...
► Artikel lesen
18.07.23TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination222New York, NY, July 18, 2023 (GLOBE NEWSWIRE) -- TenX Keane Acquisition (the "Company") (NASDAQ: TENKU) today announced that, in order to extend the date by which the Company must complete its initial...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1